Category Archives: The IPO Buzz

December opens with just one IPO on the calendar – in keeping with the trend for the first week of December over the past five years. Nevertheless, there is hope in the wind. Here are a few big names in the wings that have caught the attention of some IPO investors: Bill.com Holdings (BILL proposed), […]

This week’s IPO Calendar has just two deals – a new name and a carryover from last week. This lean Thanksgiving menu is not at all unusual. The IPO world usually slows down for the week of the Thanksgiving Day holiday. The new name is Alussa Energy Acquisition (ALUSU proposed) while LMP Automotive Holdings (LMPX […]

Chips and SPACs are in the spotlight on this week’s IPO Calendar. And there’s big news about an IPO that the American public can’t buy – the long-awaited Saudi Aramco deal. (More on that gigantic IPO in a minute.) Bankers plan to price eight IPOs this week and raise about $684 million. Two chip companies […]

Two IPOs slipped on to the IPO Calendar late Thursday afternoon for pricing during the week of Nov. 18. That gave Wall Street some IPO action for the third week of November, when previously there was none. This isn’t to say that things have turned quiet. November 2019 is off to a better-than-usual start.(There’s just […]

The first week of November features a $2.4 billion IPO Calendar, with one deal – GFL Environmental – accounting for most of that volume. GFL, the Canadian trash and recycling giant, aims to raise $1.9 billion. It’s among 10 IPOs on tap this week. Health care is the dominant sector this week. Five of the […]

Just three IPOs are on the calendar this week, when Halloween falls on Thursday.  That’s a wrap as well for October.  A cannabis SPAC, a biotech and an online platform for Chinese real estate agents are in this week’s IPO mix. Bankers expect these three deals to raise $283 million, based on the midpoint of […]

A fertility benefits management company is among eight deals on this week’s IPO Calendar. Bankers expect to raise $830.5 million. Progyny (PGNY proposed) manages fertility benefits for some of the country’s most prominent employers, its prospectus says. Some would say that Progyny’s IPO is a sign of the times. More employers are offering insurance coverage […]

You probably wouldn’t buy a car or make any other major purchase without doing some homework. The same rule applies to buying stock in an IPO. Reading the prospectus isn’t just fundamental. It could prevent heartburn or a hole in your bank account. Just three deals are on tap this week, and only two are […]

Two biotechs and a Midwestern bank make up this week’s IPO Calendar. That’s it. Bankers expect to raise $550.22 million from these three deals. This lineup extends the trend last week when five biotechs plus a Southern bank were set to go public. Two of those five biotech deals got pulled last week “due to […]

It seems every time the IPO Calendar starts to run dry, you can count on bankers filling up the pages with healthcare deals. This week is a classic example. Six IPOs are on tap for the first week of October – and five are in the healthcare sector, either biotech or biopharma companies. (We’ll have […]